Related Experiment Video
Updated: Nov 26, 2025

06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.9K
Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade
Katarzyna Winek1,2, Sebastian Lobentanzer3, Bettina Nadorp1,4
1The Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel.
Summary
Following stroke, blood shows decreased microRNAs and increased transfer RNA fragments (tRFs) that target immune responses. This small RNA shift impacts immune cell function and offers new therapeutic targets for stroke recovery.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Stroke recovery hinges on balancing immune responses, but molecular regulators are unknown.
- Peripheral cholinergic pathways modulate immune reactions, yet their specific controllers remain elusive.
- Understanding post-stroke immune dynamics is crucial for developing effective treatments.
Purpose of the Study:
- To identify molecular regulators of immune response shifts after ischemic stroke.
- To investigate changes in small RNA profiles in stroke patients.
- To explore the role of specific small RNAs and immune cells in post-stroke homeostasis.
Main Methods:
- Small RNA sequencing of patient blood 2 days post-ischemic stroke.
- Validation of differentially expressed microRNAs and transfer RNA fragments (tRFs) using qRT-PCR.
- Analysis of independent RNA sequencing datasets to identify key immune cell subsets.
- In vitro stimulation of immune cells and functional assays with specific tRFs.
Main Results:
- A significant shift in small RNA profiles was observed, with decreased microRNA and increased tRF levels.
- Top upregulated tRFs were validated in stroke patients and implicated CD14+ monocytes.
- tRFs were shown to target cholinergic transcripts and modulate immune regulator Z-DNA binding protein 1.
- Lipopolysaccharide stimulation confirmed tRF upregulation in immune cells.
Conclusions:
- A regulatory shift between microRNA and tRF types occurs post-stroke, affecting immune homeostasis.
- CD14+ monocytes play a key role in the cholinergic inflammatory reflex following stroke.
- Identified pathways and small RNAs present novel therapeutic and biomarker opportunities for stroke.
Related Concept Videos
Experimental RNAi
6.9K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.9K
MicroRNAs
23.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
RNA Interference
27.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.2K

